A common question from patients considering the ChondroFiller injection is a practical one: if nothing is stitched or glued in, what actually keeps the material where it needs to be? The answer lies in the physical chemistry of the scaffold itself — and in careful technique during delivery.
What ChondroFiller Is
ChondroFiller is a Class III CE-marked medical device consisting of a type I collagen hydrogel. It is supplied as a liquid in a double-chamber syringe. When the two components are mixed during injection, a pH shift triggers the collagen fibres to cross-link and form a semi-solid gel — a process called in-situ gelation. This happens at body temperature and is complete within approximately three to five minutes.
The ChondroFiller injection is a non-surgical, outpatient procedure: no theatre, no incision, no general anaesthetic. The material is delivered under ultrasound guidance directly into the cartilage defect.
How It Stays in Place
Several factors work together to keep the gel securely within the defect after injection.
Preparation of the defect surface
Before the gel is delivered, the target area is carefully prepared and dried. Residual irrigation fluid or joint fluid would dilute or displace the collagen solution before it can gel. Removing that fluid — using careful technique — is an important step that determines how well the material settles and bonds.
In-situ gelation and moulding
Because ChondroFiller is liquid at the point of injection and gels in place, it fills the three-dimensional contours of the worn area precisely, including irregular margins that a pre-formed implant could not reach. As it sets, the gel conforms to the shape of the defect rather than sitting loosely on top of it.
Natural adhesion to the surrounding tissue
Once gelled, the hydrogel forms stable bonds with the fibrin naturally present in the surrounding cartilage and subchondral bone. This intrinsic adhesion — without sutures or external fibrin glue — is what holds the implant securely in place during normal joint movement. The scaffold's self-adherent properties are part of its Class III CE device specification.
A Supportive Collagen Layer
Once in place, the gelled scaffold provides a structural collagen matrix over the worn surface. Because it is type I collagen — the same protein found in native connective tissue — the material is biologically compatible and, in published studies, has been shown to attract the body's own progenitor cells into the defect, where they may begin to synthesise new cartilage-like tissue over time.
It is important to be clear about what this means in practice. ChondroFiller is best understood as a biologically supportive, joint-preserving scaffold. It is not a guaranteed repair, and it does not cure or reverse arthritis. The published evidence suggests that many patients experience meaningful improvements in pain and function, but individual responses vary.
Evidence and Outcomes
Experience with ChondroFiller and acellular collagen-matrix injections for cartilage defects is encouraging, though the evidence base is still developing. A 2023 study examining the use of the acellular collagen matrix ChondroFiller Liquid for trapeziometacarpal osteoarthritis reported improvements in pain and grip strength (Corain, M., Zanotti, F., Giardini, M., Gasperotti, L., Invernizzi, E., Biasi, V., & Lavagnolo, U., 2023, The use of an acellular collagen matrix ChondroFiller Liquid for trapeziometacarpal osteoarthritis, Cartilage). Responses are not uniform, and benefits cannot be guaranteed.
Conclusion
ChondroFiller stays in place without stitches because its liquid form gels within the defect itself, moulds to the surface, and bonds naturally to the surrounding tissue. Recovery from the ChondroFiller injection is typically straightforward because no incision is made. For some patients it may help support a worn joint, but it is not a cure for arthritis.
At the London Cartilage Clinic, Professor Paul Lee and his team assess whether the ChondroFiller injection is appropriate for each individual, using precise ultrasound-guided technique and providing realistic expectations throughout. To discuss whether it may be suitable for you, a consultation is the appropriate first step.
References
Corain, M., Zanotti, F., Giardini, M., Gasperotti, L., Invernizzi, E., Biasi, V., & Lavagnolo, U. (2023). The use of an acellular collagen matrix ChondroFiller Liquid for trapeziometacarpal osteoarthritis. Cartilage.
Frequently Asked Questions
- ChondroFiller is liquid when injected and gels in place within three to five minutes, moulding to the shape of the worn surface. It then forms natural bonds with the fibrin in the surrounding tissue, holding it securely without sutures or surgical fixation.
- It is a non-surgical, stitch-free outpatient injection delivered under ultrasound guidance. Unlike surgical procedures that require theatre and anaesthetic, ChondroFiller is placed directly into the defect through a guided injection, with no incision. It is a biologically supportive scaffold, not a guaranteed repair, and it does not cure arthritis.
- Very important. The defect area must be properly dried before delivery so the collagen solution can gel and adhere effectively. Precise, ultrasound-guided placement and careful patient selection are key factors in achieving a worthwhile result.
- Published clinical data are encouraging but still developing. In a 2023 study of thumb-base osteoarthritis, improvements in pain and grip strength were reported. Broader evidence in knee and hip joints also supports a meaningful improvement in patient-reported outcomes over 12 to 36 months for many patients, though individual responses vary and benefits cannot be guaranteed.
- Suitability depends on factors including the site, size and grade of the cartilage defect, the joint involved, overall joint health, and individual patient factors. A specialist assessment is needed to determine whether the ChondroFiller injection is appropriate, or whether a surgical approach such as the Liquid Cartilage protocol — a keyhole procedure used for larger or more complex defects — would be more suitable.
Where to go from here
A few next steps tailored to what you have just read.
Legal & Medical Disclaimer
This article is written by an independent contributor and reflects their own views and experience, not necessarily those of London Cartilage Clinic. It is provided for general information and education only and does not constitute medical advice, diagnosis, or treatment.
Always seek personalised advice from a qualified healthcare professional before making decisions about your health. London Cartilage Clinic accepts no responsibility for errors, omissions, third-party content, or any loss, damage, or injury arising from reliance on this material.
If you believe this article contains inaccurate or infringing content, please contact us at [email protected].
